Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Cancer research

Prelude Therapeutics
Regional

Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025

November 11, 2025November 10, 2025 - by Timothy Alexander

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the publication of two abstracts featuring preclinical data from its JAK2V617F mutant-selective inhibitor program and CALR-targeted degrader antibody conjugates (DACs) discovery …

Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025 Read More

National Comprehensive Cancer Network
Cancer / Regional

NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives

October 7, 2025October 6, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced new funding to support quality improvement projects aimed at advancing breast cancer outcomes. The …

NCCN Oncology Research Program Announces New Funding for Breast Cancer Quality Initiatives Read More
CertaPro Painters Paint it Pink
Regional

CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research

October 7, 2025October 6, 2025 - by Timothy Alexander

AUDUBON, PA — CertaPro Painters® has launched its seventh annual Paint it Pink campaign in partnership with the Breast Cancer Research Foundation (BCRF) and Breast Cancer Canada, continuing its mission …

CertaPro Painters Launches Seventh Annual ‘Paint It Pink’ Campaign for Breast Cancer Research Read More

Medical research
Regional

Dispatch Bio Launches With $216M and Bold Mission to Tackle All Solid Tumors

July 28, 2025July 26, 2025 - by Timothy Alexander

PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio emerged from stealth this past week with a mission as ambitious as it is urgent: to develop a universal treatment for …

Dispatch Bio Launches With $216M and Bold Mission to Tackle All Solid Tumors Read More
ChristianaCare
Regional

New ChristianaCare Study Pinpoints Causes Behind Delaware’s Breast Cancer Hotspots

July 28, 2025July 26, 2025 - by Timothy Alexander

WILMINGTON, DE — A groundbreaking study by ChristianaCare’s Cawley Center for Translational Cancer Research has identified key factors behind Delaware’s elevated rates of advanced breast cancer and laid the groundwork for …

New ChristianaCare Study Pinpoints Causes Behind Delaware’s Breast Cancer Hotspots Read More

National Comprehensive Cancer Network
Regional

NCCN Awards Grants to Advance Innovative Lung Cancer Research on Zipalertinib

July 13, 2025July 12, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has awarded two new research grants to support studies on zipalertinib, a promising therapy for Non-Small …

NCCN Awards Grants to Advance Innovative Lung Cancer Research on Zipalertinib Read More
National Comprehensive Cancer Network
Research

Telehealth Program Improves Quality of Life for Older Cancer Patients, Study Finds

June 15, 2025June 14, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — A new study published in the June 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights the life-changing impact of a telehealth-based care program …

Telehealth Program Improves Quality of Life for Older Cancer Patients, Study Finds Read More

SEED Therapeutics
Regional

SEED Therapeutics Unveils Groundbreaking Advances in Cancer Research at AACR 2025

May 9, 2025May 8, 2025 - by Timothy Alexander

KING OF PRUSSIA, PA — SEED Therapeutics Inc. presented compelling developments from its cancer research programs at the 2025 Annual Meeting of the American Association for Cancer Research (AACR) in …

SEED Therapeutics Unveils Groundbreaking Advances in Cancer Research at AACR 2025 Read More
Medical news
Regional

SK Life Science Labs Unveils Breakthrough in Cancer Therapy with PVTX-405

May 6, 2025May 5, 2025 - by Timothy Alexander

KING OF PRUSSIA, PA — SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent …

SK Life Science Labs Unveils Breakthrough in Cancer Therapy with PVTX-405 Read More
Context Therapeutics
Regional

Context Therapeutics Showcases Promising CT-95 Data at AACR Annual Meeting

May 4, 2025May 3, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) presented preclinical and translational data on its clinical asset, CT-95, at the 2025 American Association for Cancer Research (AACR) Annual Meeting. The …

Context Therapeutics Showcases Promising CT-95 Data at AACR Annual Meeting Read More

Posts pagination

1 2 3 Next

Trending News

  • Wallingford Man Arrested in Fatal Chester Motorcycle Crash Investigation

  • Prestigious National Award Puts Spotlight on Valley Township Police Leadership

  • High Street Slowdowns Ahead as Business 322 Safety Upgrades Push Forward

  • Troubling Violations Spark Fresh Scrutiny at Exton Pizza Shop

  • Police Seek Suspect After Retail Theft Reported at North Wales Ulta Beauty

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Thomas John Hibbert

Wallingford Man Arrested in Fatal Chester Motorcycle Crash Investigation

December 6, 2025December 6, 2025

Suspect

Police Seek Suspect After Retail Theft Reported at North Wales Ulta Beauty

December 6, 2025December 6, 2025

Lafel Crawford Jr.

Shots-Fired Call Leads to Gun Allegations and Arrest on Superfine Lane

December 6, 2025December 6, 2025

Copyright © 2025 MyChesCo.